Phil Wolfson, MD

Phil Wolfson, MD

Phil Wolfson, MD, is president & CEO of the non-profit Ketamine Research Foundation and directs the training of KAP practitioners through The Ketamine Training Center. Phil’s book The Ketamine Papers is the seminal work in the burgeoning ketamine arena. He is principal investigator for the MAPS sponsored Phase 2, the FDA-approved 18-person study of MDMA Assisted Psychotherapy for individuals with significant anxiety due to life threatening illnesses. His clinical practice with ketamine has informed his leadership role in the development of Ketamine Assisted Psychotherapy.